|
Prescription Drug Search
Strengths available for Sustiva:
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about CancerDrugsDirect.com
List of countries where we can ship Sustiva:
- Anguilla
- Antigua and Barbuda
- Aruba
- Australia
- Bangladesh
- Barbados
- Brazil
- Bulgaria
- Cuba
- Denmark
- Dominican Republic
- El Salvador
- Estonia
- Fiji
- Greece
- Guatemala
- India
- Indonesia
- Iran
- Italy
- Jordan
- Korea, Republic of
- Kuwait
- Lithuania
- Monaco
- Netherlands
- New Zealand
- Peru
- Philippines
- Portugal
- Qatar
- Russian Federation
- Saint Lucia
- Serbia
- Seychelles
- Singapore
- Taiwan
- United Kingdom, UK
- United States, US
- Uzbekistan
Latest news releases on Sustiva:
Gilead’s Quad Pill Raises Kidney Questions, FDA Says - Bloomberg
The therapy mixes Gilead’s two-drug medicine Truvada, approved in 2004, with Bristol-Myers Squibb Co. (BMY)’s Sustiva. Quad contains four Gilead compounds in a single pill that patients take once a day. An FDA review of studies funded by ...
Gilead’s HIV Quad Pill Wins Backing From FDA Advisers - Bloomberg
The therapy mixes Gilead’s two-drug medicine Truvada, approved in 2004, with Bristol-Myers Squibb Co. (BMY)’s Sustiva. Quad contains four Gilead compounds in a single pill that patients take once a day. Patients taking the drugs were less ...
HIV Drug Maker Gilead Sciences Scores Two Wins - Minyanville
Like Quad, Atripla is a once-daily pill combining medicines -- two Gilead drugs and Bristol-Myers Squibb’s (BMY) Sustiva. The neurological side effects of Atripla are attributed to Sustiva, which is not included in Gilead’s Quad. Quad is a ...
4 Large Cap Dividend Stocks With Strong Profits That Analysts Rate As Buy - Seekingalpha.com
The company's principal products also comprise SUSTIVA for the treatment of HIV; BARACLUDE, an inhibitor of hepatitis B virus; ERBITUX to target and block the epidermal growth factor receptor; SPRYCEL for treatment of chronic myeloid leukemia in adults ...
BUYINS.NET: Market Maker Surveillance Report. MS, T, JPM, BMY, … - TMCnet
The companys principal products also comprise SUSTIVA for the treatment of HIV; BARACLUDE, an inhibitor of hepatitis B virus; ERBITUX to target and block the epidermal growth factor receptor; SPRYCEL for treatment of chronic myeloid leukemia in ...
Op-ed: Riding Is Like Choosing to Live - Advocate
My T-cell count was two. And my viral load was off the chart. My doctor immediately put me on a cocktail of Sustiva and Combivir. I spent that next month in the hospital. Five years or so later he changed my cocktail regimen to Atripla ...
The Global Antivirals Market Expected To Reach $30 Billion By 2017 - OfficialWire
Some major patent expiries are expected during the forecast period, such as for Sustiva, Combivir, Tenofovir, Telbivudine, Tamiflu and Relenza. The patent expiries of these blockbuster drugs will trigger generic competition in the antivirals market ...
